Device pricing reduced when hospital takes over rep/distributor duties
Recorded opinion date:
The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.
What OIG Said
OIG said this model is okay if the lower price reflects services no longer provided, not a hidden benefit to induce purchasing.
✓A device manufacturer offered hospitals a lower price on spinal implants if the hospital took on logistics and training tasks usually done by a distributor or sales rep.
✓OIG acknowledged this could look like remuneration, which raises Anti-Kickback concerns if the price cut is viewed as an inducement.
✓But OIG accepted the price cut because it matched the value of services the manufacturer no longer had to pay for, making the structure commercially reasonable, not a kickback.
✓Hospitals still had to perform all the rep duties internally, meaning they weren’t getting a “free benefit,”
just paying only for what they used.
OIG WATCH | info@cabraconsulting.com
Diligence Checklist
What you need to be ready to show in diligence
✓Show that your pricing difference equals the cost of the services removed, not a made-up “discount.”
✓Document what services would have been included in the standard price and who now performs them.
✓Prove the hospital is actually doing the work, not getting a lower price without real substitution.
✓Keep a clean, written agreement outlining scope, roles, term, and fallback terms if performance fails.
If you’re offering price breaks, but can’t tie them to reduced service costs, it may read like paying for purchasing loyalty.
OIG WATCH | info@cabraconsulting.com
Structure not diligence-ready?
Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.
OIG WATCH | info@cabraconsulting.com
Original PDF cover text
FAVORABLE
OIG WATCH
21-06
Device pricing reduced when hospital takes over rep/distributor duties
Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.
The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.
What OIG Said
OIG said this model is okay if the lower price reflects services no longer provided, not a hidden benefit to induce purchasing.
✓A device manufacturer offered hospitals a lower price on spinal implants if the hospital took on logistics and training tasks usually done by a distributor or sales rep.
✓OIG acknowledged this could look like remuneration, which raises Anti-Kickback concerns if the price cut is viewed as an inducement.
✓But OIG accepted the price cut because it matched the value of services the manufacturer no longer had to pay for, making the structure commercially reasonable, not a kickback.
✓Hospitals still had to perform all the rep duties internally, meaning they weren’t getting a “free benefit,”
just paying only for what they used.
OIG WATCH | info@cabraconsulting.com
Diligence Checklist
What you need to be ready to show in diligence
✓Show that your pricing difference equals the cost of the services removed, not a made-up “discount.”
✓Document what services would have been included in the standard price and who now performs them.
✓Prove the hospital is actually doing the work, not getting a lower price without real substitution.
✓Keep a clean, written agreement outlining scope, roles, term, and fallback terms if performance fails.
If you’re offering price breaks, but can’t tie them to reduced service costs, it may read like paying for purchasing loyalty.
OIG WATCH | info@cabraconsulting.com
Structure not diligence-ready?
Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.
OIG WATCH | info@cabraconsulting.com
Original PDF cover text
FAVORABLE
OIG WATCH 21-06
Device pricing reduced when hospital takes over rep/distributor duties
Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.